MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness

Not Applicable
Completed
Conditions
Contact Lens Wear
Interventions
Other: FID 112903
First Posted Date
2010-05-28
Last Posted Date
2016-11-21
Lead Sponsor
Alcon Research
Target Recruit Count
92
Registration Number
NCT01132287

Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery

First Posted Date
2010-05-14
Last Posted Date
2013-06-19
Lead Sponsor
Alcon Research
Target Recruit Count
80
Registration Number
NCT01124045
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

Phase 4
Completed
Conditions
Allergic Conjunctivitis
Interventions
First Posted Date
2010-05-07
Last Posted Date
2014-02-28
Lead Sponsor
Alcon Research
Target Recruit Count
180
Registration Number
NCT01119287
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Travoprost Five Day Posology Study

Phase 2
Completed
Conditions
Open-angle Glaucoma (OAG)
Ocular Hypertension
Interventions
First Posted Date
2010-05-03
Last Posted Date
2011-06-23
Lead Sponsor
Alcon Research
Target Recruit Count
60
Registration Number
NCT01114893
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension

Phase 4
Completed
Conditions
Glaucoma
Ocular Hypertension
Interventions
First Posted Date
2010-04-28
Last Posted Date
2015-07-29
Lead Sponsor
Alcon Research
Target Recruit Count
70
Registration Number
NCT01111890

Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 Years

Terminated
Conditions
Otorrhea
First Posted Date
2010-04-28
Last Posted Date
2012-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
1389
Registration Number
NCT01111877
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Confirmatory Study Nepafenac 0.3%

Phase 3
Completed
Conditions
Cataract
Interventions
Other: Nepafenac Ophthalmic Suspension 0.3% Vehicle
Other: NEVANAC Vehicle
First Posted Date
2010-04-23
Last Posted Date
2012-11-30
Lead Sponsor
Alcon Research
Target Recruit Count
2120
Registration Number
NCT01109173
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Phase 4
Completed
Conditions
Allergic Conjunctivitis
Interventions
First Posted Date
2010-04-23
Last Posted Date
2015-05-12
Lead Sponsor
Alcon Research
Target Recruit Count
42
Registration Number
NCT01109485
Locations
🇯🇵

Contact Alcon Call Center For Trial Locations, Tokyo, Japan

Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye

Phase 4
Completed
Conditions
Post Menopausal Dry Eye Subjects
Interventions
Other: Systane Ultra Lubricant Eye Drops
Other: Sensitive Eyes Eye Drops (Bausch & Lomb)
First Posted Date
2010-04-19
Last Posted Date
2016-11-18
Lead Sponsor
Alcon Research
Target Recruit Count
70
Registration Number
NCT01105910

A Comparative Pilot Study Of High-Order Aberrations With Aspheric IOL Models SN60WF and ZCB00

Not Applicable
Completed
Conditions
Cataracts
Interventions
Device: Tecnis 1-piece Aspheric Acrylic (ZCB00) IOL
Device: AcrySof Natural IQ (SN60WF) IOL
First Posted Date
2010-04-16
Last Posted Date
2012-11-29
Lead Sponsor
Alcon Research
Target Recruit Count
20
Registration Number
NCT01105585
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath